Survival analysis indicates that patients whose tumor stained 3+ for GP88 had an HR of 5.9-fold corresponding to a dramatic increase in probability of recurrence compared with patients whose tumors had no or low GP88 expression. The gene discussed is GRN; the disease is neoplasm.